Mona Ashiya
InvestorGeneral Partner at OrbiMed · Board director at Vanqua Bio · Board director at Prevail Therapeutics
New York, New York
Writes $1M – $75M checks · typically $4M
About
Mona Ashiya is a General Partner at OrbiMed, which she joined in 2010. She previously worked on J.P. Morgan's biotechnology equity research team and held positions at the Global Alliance for TB Drug Development and Harvard Business School. She holds a B.A. from the University of California, Berkeley, a Ph.D. in Cellular, Molecular, and Developmental Biology from the University of Pittsburgh, and completed a post-doctoral fellowship at the Dana Farber Cancer Institute.
Invests in
Biotech
Board director at Vanqua Bio
Intro paths
In turn, Mona can intro founders to Vanqua Bio's investors below.
Vanqua Bio's investors · 2
Board director at Prevail Therapeutics
Intro paths
In turn, Mona can intro founders to Prevail Therapeutics's investors below.
Prevail Therapeutics's investors · 1
Co-founders at Prevail Therapeutics
Experience
- OrbiMed AdvisorsPrivate Equity Partnercurrent2010 — presentNew York, NY
Skills & more
From Mona's professional profile.
Deals · 2
Vanqua BioBoard seat
via OrbiMed · filed Sep 2021 · $85M raise
Prevail TherapeuticsBoard seat
via OrbiMed · filed Mar 2018 · $65M raise
Attribution from SEC filings, press coverage, and firm rosters.
Colleagues at OrbiMed
Network1
Investors connected to Mona in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Mona Ashiya?
- Mona Ashiya is a General Partner at OrbiMed, which she joined in 2010. She previously worked on J.P. Morgan's biotechnology equity research team and held positions at the Global Alliance for TB Drug Development and Harvard Business School. She holds a B.A. from the University of California, Berkeley, a Ph.D. in Cellular, Molecular, and Developmental Biology from the University of Pittsburgh, and completed a post-doctoral fellowship at the Dana Farber Cancer Institute.
- Where does Mona Ashiya work?
- Mona Ashiya is General Partner at OrbiMed and Board director at Vanqua Bio and Board director at Prevail Therapeutics.
- What does Mona Ashiya invest in?
- Mona Ashiya invests in Biotech.
- What check size does Mona Ashiya write?
- Mona Ashiya typically writes checks of $1M – $75M.
- What boards does Mona Ashiya sit on?
- Mona Ashiya holds tracked board seats at Prevail Therapeutics, Vanqua Bio.